Paper4186599
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.
Wemambu SN and 3 others. Lancet, 1969. Cited by 308 papers, by iCite.
Cite this record
ConductScience Library. Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Papers, record 4186599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4186599
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthus Reaction | Major topic |
| Leprosy | Major topic |
| Skin Manifestations | Major topic |
| Antigens | |
| Complement System Proteins | |
| Erythema | |
| Fluorescent Antibody Technique | |
| Humans | |
| Mycobacterium leprae | |
| Skin | |
| gamma-Globulins |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03775460 | Methotrexate and Prednisolone Study in Erythema Nodosum Leprosum | Background |
Source ClinicalTrials.gov
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 308 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41863863 | Laboratory and functional tests in leprosy diagnosis: a practical guide for clinical decision-making. | An Bras Dermatol | 2026 | https://conductscience.org/library/papers/41863863 | PubMed |
| 39072336 | Neutrophilic leukocytosis and erythema nodosum leprosum in leprosy: insights from a retrospective observational study. | Front Immunol | 2024 | https://conductscience.org/library/papers/39072336 | PubMed |
| 37809252 | Leprosy Classification, Clinical Features, Epidemiology, and Host Immunological Responses: Failure of Eradication in 2023. | Cureus | 2023 | https://conductscience.org/library/papers/37809252 | PubMed |
| 35867720 | Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function. | PLoS Negl Trop Dis | 2022 | https://conductscience.org/library/papers/35867720 | PubMed |
| 34746168 | Host-Related Laboratory Parameters for Leprosy Reactions. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34746168 | PubMed |
| 32832433 | What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum. | Indian Dermatol Online J | 2020 | https://conductscience.org/library/papers/32832433 | PubMed |
| 30949168 | Neutrophils in Leprosy. | Front Immunol | 2019 | https://conductscience.org/library/papers/30949168 | PubMed |
| 30652669 | Involvement of TNF-Producing CD8+ Effector Memory T Cells with Immunopathogenesis of Erythema Nodosum Leprosum in Leprosy Patients. | Am J Trop Med Hyg | 2019 | https://conductscience.org/library/papers/30652669 | PubMed |
| 29028793 | Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/29028793 | PubMed |
| 28991896 | T-cell regulation in Erythema Nodosum Leprosum. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28991896 | PubMed |
| 28505186 | In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin. | PLoS One | 2017 | https://conductscience.org/library/papers/28505186 | PubMed |
| 28348555 | A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. | Front Immunol | 2017 | https://conductscience.org/library/papers/28348555 | PubMed |
| 27556927 | Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/27556927 | PubMed |
| 26749503 | Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy. | Clin Exp Immunol | 2016 | https://conductscience.org/library/papers/26749503 | PubMed |
| 26351858 | ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/26351858 | PubMed |
| 26304919 | Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic. | Am J Trop Med Hyg | 2015 | https://conductscience.org/library/papers/26304919 | PubMed |
| 24770503 | Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day. | An Bras Dermatol | 2014 | https://conductscience.org/library/papers/24770503 | PubMed |
| 24625394 | The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24625394 | PubMed |
| 24098819 | A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction. | PLoS Negl Trop Dis | 2013 | https://conductscience.org/library/papers/24098819 | PubMed |
| 23446220 | Lsr2 of Mycobacterium leprae and its synthetic peptides elicit restitution of T cell responses in erythema nodosum leprosum and reversal reactions in patients with lepromatous leprosy. | Clin Vaccine Immunol | 2013 | https://conductscience.org/library/papers/23446220 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4186599
GET https://conductscience.org/api/papers/v1/4186599/cited_by?page=2